Extended trimethoprim/sulfamethoxazole prophylaxis for implant reconstruction in the previously irradiated chest wall

Plastic and Reconstructive Surgery

Volumn 129, Issue 1, 2012, Pages

  Mirzabeigi, Michael N ^a   Lee, Michelle ^a   Smartt, James M ^a   Jandali, Shareef ^a   Sonnad, Seema S ^a   Serletti, Joseph M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE;

ADULT; ALGORITHM; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BREAST ENDOPROSTHESIS; BREAST TUMOR; FEMALE; HUMAN; INFECTION; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIATION EXPOSURE; RETROSPECTIVE STUDY; STATISTICAL MODEL; THORAX WALL;

ADULT; ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BREAST IMPLANTS; BREAST NEOPLASMS; CEPHALOSPORINS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; THORACIC WALL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84555191858     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182362027     Document Type: Article

References (51)

1. Wolfe SA, Podda S. Prophylactic antibiotics in aesthetic surgery. Aesthet Surg J. 2006;26:93-94.
2. Krizek TJ, Koss N, Robson MC. The current use of prophylactic antibiotics in plastic and reconstructive surgery. Plast Reconstr Surg. 1975;55:21-32.
3. Krizek TJ, Gottlieb LJ, Koss N, Robson MC. The use antibacterials in plastic surgery: A 1980s update. Plast Reconstr Surg. 1985;76:953-963.
4. Lyle WG, Outlaw K, Krizek TJ, Koss N, Payne WG, Robinson MC. Prophylactic antibiotics in plastic surgery: Trends of use over 25 years of an evolving specialty. Aesthet Surg J. 2003; 23:177-183.
5. Peled IJ, Dvir G, Berger J, Ramon I, Ullmann Y, Nachlieli T. Prophylactic antibiotics in aesthetic and reconstructive surgery. Aesthetic Plast Surg. 2000;24:299-302.
6. Perrotti JA, Castor SA, Perez PC, Zins JE. Antibiotic use in aesthetic surgery: A national survey and literature review. Plast Reconstr Surg. 2002;109:1685-1693; discussion 1694-1695.
7. Rohrich RJ, Rios JL. The role of prophylactic antibiotics in plastic surgery: Whom are we treating? Plast Reconstr Surg. 2003;112:617-618.
8. Khan UD. Breast augmentation, antibiotic prophylaxis, and infection: Comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration. Aesthetic Plast Surg. 2010;34: 42-47.
9. Mirzabeigi MN, Abdollahi H, Ortlip T, et al. The efficacy of postoperative prophylactic antibiotics in primary and secondary cosmetic breast augmentation. Paper presented at: 2010 Annual Meeting of the American Society of Aesthetic Plastic Surgeons; April 25, 2010; Washington, DC.
10. Gravante G, Caruso R, Araco A, Cervelli V. Infections after plastic procedures: Incidences, etiologies, risk factors, and antibiotic prophylaxis. Aesthetic Plast Surg. 2008;32:243-251.
11. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis. 2005;5:94-106.
12. Nahabedian MY, Tsangaris TM, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467-476.
13. Roostaeian J, Pavone L, Da Lio A, Lipa J, Festekjian J, Crisera C. Immediate placement of implants in breast reconstruction: Patient selection and outcomes. Plast Reconstr Surg. 2011;127:1407-1416.
14. Cordeiro PG, McCarthy CM. A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: Part I. A prospective analysis of early complications. Plast Reconstr Surg. 2006;118:825-831.
15. Handel N, Jensen JJ, Black Q, Waisman JR, Silverstein MJ. The fate of breast implants: A critical analysis of complications and outcomes. Plast Reconstr Surg. 1995;96:1521-1533.
16. Evans GR, Schusterman MA, Kroll SS, et al. Reconstruction and the radiated breast: Is there a role for implants? Plast Reconstr Surg. 1995;96:1111-1115; discussion 1116-1118.
17. Spear SL, Seruya M, Clemens MW, Teitelbaum S, Nahabedian MY. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Reconstr Surg. 2011;127:1047-1058.
18. Francis SH, Ruberg RL, Stevenson KB, et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg. 2009;124:1790-1796.
19. Percec I, Bucky LP. Successful prosthetic breast reconstruction after radiation therapy. Ann Plast Surg. 2008;60:527-531.
20. Spear SL, Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: Recent trends and therapeutic implications. Plast Reconstr Surg. 2000;105: 930-942.
21. Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg. 2006;117:359-365.
22. Armstrong RW, Berkowitz RL, Bolding F. Infection following breast reconstruction. Ann Plast Surg. 1989;23:284-288.
23. Krueger EA, Wilkins EG, Strawderman M, et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49:713-721.
24. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82B Trial. N Engl J Med. 1997; 337:949-955.
25. Ragaz K, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-962.
26. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116-126.
27. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: An overview of the randomized trials. Lancet 2005;366:2087-2106.
28. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer. Lancet 2009;373:1463-1479.
29. National Clearinghouse of Plastic Surgery Statistics. ASPS 2011 report of the 2010 statistics. Available at: http://www.plasticsurgery.org/Media/ Statistics.html. Accessed April 8, 2011.
30. Zhanel GG, Adam HJ, Low DE, et al. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: Results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis. 2011;69:291-306.
31. Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: Two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg. 2002;109:2265-2274.
32. Kalkut G. Sulfonamides and trimethoprim. Cancer Invest. 1998;16:612-615.
33. Kenna DM, Robotti EB, Bocchiotti G, Blazek J, Grossman JAI. Diffusion of antibiotics across tissue expanders: An in vitro study. Ann Plast Surg. 1994;32:346-349; discussion 349-350.
34. Nahabedian MY. AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. Plast Reconstr Surg. 2009;124:1743-1753.
35. Disa JJ, Ad-El DD, Cohen SM, Cordiero PG, Hidalgo DA. The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg. 1999;104:1662-1665.
36. Chun JK, Schulman MR. The infected breast prosthesis after mastectomy reconstruction: Successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg. 2007; 120:581-589.
37. Spear SL, Seruya M. Management of the infected or exposed breast prosthesis: A single surgeon's 15-year experience and 69 patients. Plast Reconstr Surg. 2010;125:1074-1084.
38. Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg. 1979;63:812-816.
39. Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty-associated mycobacterial infection: A survey of plastic surgeons. Plast Reconstr Surg. 1983;72:165-169.
40. Trotter JF, Levi M, Steinberg T, Lancaster J. Absence of Pneumocystis jiroveci pneumonia in liver transplantation recipients receiving short-term (3-month) prophylaxis. Transpl Infect Dis. 2008;10:369-371.
41. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: Systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82: 1052-1059.
42. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis. 2003;188:706-718.
43. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111:1605-1611.
44. AdamsWPJr. Capsular contracture? What causes it? How can it be prevented and managed? Clin Plast Surg. 2009;36:119-126.
45. Schreml S, Heine N, Eisenmann-Klein M, Prantl L. Bacterial colonization is of major relevance for high-grade capsular contracture after augmentation mammaplasty. Ann Plast Surg. 2007;59:126-130.
46. Netscher DT. Subclinical infection as a possible cause of significant breast capsules. Plast Reconstr Surg. 2004;113: 2229-2230.
47. Rieger UM, Pierer G, Lüscher NJ, Trampuz A. Sonication of removed breast implants for improved detection of subclinical infection. Aesthetic Plast Surg. 2009;33:404-408.
48. Tamboto H, Vickery K, Deva AK. Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty. Plast Reconstr Surg. 2010; 126:835-844.
49. Adams WP Jr, Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: Six-year prospective clinical study. Plast Reconstr Surg. 2006;117:30-36.
50. Adams WP Jr, Conner CH, Barton FE Jr, Rohrich RJ. Optimizing breast pocket irrigation: An in vitro study and clinical implications. Plast Reconstr Surg. 2000;105:334-338; discussion 339-343.
51. Costerton JW, Montanaro L, Aricola CR. Biofilm in implant infections: Its production and regulation. Int J Artif Organs 2005;28:1062-1068.